Lumier Pharma LLC (manufacturing of bulk products from the manufacturer Nippon Kayaku Co., Ltd., Takasaki Plant, Japan)

The drug is used to treat squamous cell carcinoma of the head, neck, esophagus, and cervix, Hodgkin's disease, non-Hodgkin lymphomas, testicular cancer, as well as for palliative therapy of malignant pleural effusion.

Dosage form: lyophilisate for solution for injection

ATC: L01DC01